ʻO ka waihona kālā ʻo Molecular Partners AG i ka makahiki 2026: ke kumukūʻai o ka ʻāpana, ka pipeline a me ka loiloi
Ke aʻo nei ʻoe Nā ʻāpana o Molecular Partners AG ʻO ka hui biotech Swiss, i helu ʻia ma Zurich ma lalo o ka hōʻailona ticker MOLN, ke hoʻomohala nei i kahi papa o nā lāʻau lapaʻau hou e pili ana i ka ʻenehana DARPin. Aia i loko o kēia pepa ʻike ke kumukūʻai o ka mahele, ka ʻikepili o ka hui, nā hopena no nā makahiki kālā ʻekolu i hala, ke kūlana o ka pipeline, nā ikaika a me nā pilikia, a me nā kuhikuhi no ke kūʻai ʻana i ka waihona mai Farani.
Ke kumukūʻai kūʻai o nā hoa hana Molecular
Hiki ke nānā ola ʻia ke kumukūʻai mahele o Molecular Partners (MOLN) ma kāu mea kūʻai aku a i ʻole ma nā kahua kālā kuhikuhi; aia ka ʻōlelo ma Swiss francs ma Zurich a ua hōʻike kikoʻī ʻia nā hola kālepa ma lalo nei.
ʻIkepili mākeke a me ka mōʻaukala, hōʻano hou ʻia
MOLN.SW Kuikilana| Ua pani ʻia ka hoʻoikaika kino ma | ʻO Chiffre dʻaffaires | Loaʻa kālā kālā |
|---|---|---|
| 2025-12-31 | 0 CHF | -61,7 M CHF |
| 2024-12-31 | CHF 5,0 miliona | -54,0 M CHF |
| 2023-12-31 | CHF 7,0 miliona | -62,0 M CHF |
| 2022-12-31 | CHF 189,6 miliona | CHF 117,8 miliona |
ʻAʻole loaʻa ka ʻikepili mōʻaukala no kēia poʻo inoa.
Puna: Yahoo Finance, ʻikepili i hōʻiliʻili ʻia e ke kikowaena (hōʻike ʻia ka lā hōʻiliʻili ma lalo o kēlā me kēia poloka). He hōʻike wale nō ka ʻikepili a ʻaʻole ia he ʻōlelo aʻoaʻo hoʻopukapuka kālā.
No ka hoʻohālikelike ʻana me nā anamanaʻo olakino ʻē aʻe, e nānā pū i kā mākou loiloi o Waihona Lapaʻau Merit.
Palapala ʻike waihona o nā hoa hana Molecular
| hoa a pau | Nā Hoa Hana Molecular AG |
| Mākeke | ʻEono Swiss Exchange (Zurich) — hōʻailona ticker MOLN (i hōʻoia ʻia ma 27/10/2026) |
| ISIN | CH0256379097 |
| Noho | Schlieren, canton o Zurich (Switzerland) |
| ʻĀpana | ʻO ka biotechnology lapaʻau: nā lāʻau lapaʻau e pili ana i ka protein DARPin i ka oncology |
| Kūʻai kālā | Swiss franc (CHF) |
| Pau makahiki | 31 décembre |
| ʻO ke kūpono PEA | ʻAʻole (mea hoʻopuka Swiss, ma waho o EU/EEA) |
Ke Hoʻolauna nei i nā Hoa Molekala: ʻenehana a me ka Pipeline
ʻO ka ʻenehana DARPin, kahi koho ʻē aʻe i nā antibodies
Hoʻolālā ʻo Molecular Partners i nā "protein ankyrin repeat i hoʻolālā ʻia" (DARPin): nā protein liʻiliʻi, paʻa, a maʻalahi hoʻi e hana e hoʻopaʻa i nā pahuhopu olaola me ka pololei like - a ʻoi aku paha - i nā antibodies maʻamau. ʻAe kā lākou hoʻolālā modular i ka hui pū ʻana o nā kikowaena hoʻopaʻa he nui i loko o kahi mole hoʻokahi: hiki i kahi protein hoʻokahi ke kuhikuhi i kekahi mau pahuhopu i ka manawa like, no laila ka inoa ʻo multi-specific therapies.
Kuhi kēia ʻano hana i nā wahi e hakakā ai nā antibodies: nā puʻupuʻu paʻa paʻakikī e hiki aku, nā pahuhopu intracellular, a me ka pono e hoʻoikaika i ka hopena therapeutic ma ka puʻupuʻu me ka mālama ʻana i nā ʻiʻo olakino. ʻO ka hui, i hoʻokumu ʻia i ka makahiki 2004 a alakaʻi ʻia e Patrick Amstutz e like me ka ʻikepili i loaʻa ma ʻOkakopa 27, 2026, ʻo ia kekahi o nā hui ʻEulopa alakaʻi i kēia ʻenehana.
He paipu oncology lapaʻau
ʻO ka papahana holomua loa, ʻo MP0317, i loiloi ʻia ma nā hoʻokolohua pae 2 no nā ʻōpū paʻa holomua, hoʻāla i kahi pane pale kūloko i loko o ka microenvironment tumor. ʻO ka papahana MP053, kahi protein DARPin tetra-specific e hoʻopili ana i nā lymphocytes T, aia i nā hoʻokolohua pae 1 no ka hematology-oncology. Hoʻoholo kēia mau haʻawina lapaʻau i ka waiwai o ka hui: kēlā me kēia hopena—maikaʻi a maikaʻi ʻole paha—e hoʻololi nui i ke kumukūʻai kūʻai.
Hilinaʻi pū ke kumu hoʻohālike i nā hana like ʻana ma mua me nā keʻena hoʻokolohua nui, a ke hoʻomau nei kekahi o lākou i ka hoʻopuka ʻana i nā huahana hana like. Eia nō naʻe, noho mau nā loaʻa kālā a ʻaʻole hana hou: ke noho nei ka ʻoihana i ka pae hoʻopukapuka lapaʻau.
Nā hopena a me nā ʻikepili kālā o nā Molecular Partners
Nā moʻokāki i hoʻohui ʻia no nā makahiki kālā ʻekolu i hala iho nei e pau ana i Dekemaba 31, ma nā miliona o Swiss francs:
| Mea hōʻike | Makahiki kālā 2023 | Makahiki kālā 2024 | Makahiki kālā 2025 | manaʻo hoʻopuka |
|---|---|---|---|---|
| huahana | 7,0 miliona CHF | 5,0 miliona CHF | - | Loaʻa kālā ʻole mai nā hui like ʻana |
| Loaʻa kālā kālā | -62,0 MCHF | -54,0 MCHF | -61,7 MCHF | Nā pohō i ka hoʻomohala lapaʻau |
Puna: S&P Global Market Intelligence ma o StockAnalysis, nā moʻokāki i hoʻohui ʻia; ʻikepili i loaʻa ma 27/10/2026. ʻAʻole i hōʻike ʻia nā huahana 2025 ma ke kumu: ʻaʻohe hopena e huki ʻia me ka ʻole o ka nānā ʻana i nā moʻokāki kūhelu.
ʻO ke ʻano kālā, ʻo ia ka ʻoihana biotech lapaʻau: nā huahana hoʻokahi i pili i nā hui like ʻana a me nā pohō makahiki o kahi 60 miliona Swiss francs, i kālā ʻia e ke kālā i hōʻiliʻili ʻia mai nā hui nui i hala a me nā pōʻai hōʻiliʻili kālā. No laila, ʻo ke kumu nui, ʻaʻole ia ka loaʻa kālā—maikaʻi ʻole ma ke ʻano—akā, ʻo ke ala holo kālā: ka helu o nā makahiki e hiki ai i ka hui ke kālā i kāna mau hoʻokolohua ma mua o ka pono e hōʻiliʻili kālā. E nānā i nā hōʻike hou loa i paʻi ʻia no ke kahe kālā a hiki i kēia lā.
E hoʻololi i kāu waiwaiHoʻopukapuka kālā i ke kiʻiNā kiʻi pena kumu, nā ʻāpana kū hoʻokahi i kau inoa ʻia e ka mea pena kiʻi. He waiwai paʻa, mamao loa mai nā pale a me nā kumukūʻai mākeke.E nānā i nā papa →Ka mahele mahele o nā Hoa Molecular
Nā Hoa Molekala ʻaʻole e uku i nā mahele kālā a ʻaʻole loa i uku i kekahi: ma ke ʻano he ʻoihana lapaʻau, hoʻohana ia i ke kālā e hoʻolako kālā i kāna mau hoʻokolohua. Hiki i ka mea hoʻopukapuka kālā ke hilinaʻi wale i ka loiloi o ka mākeke o ka pipeline—ka holomua i nā hoʻokolohua, ke kau inoa ʻana i nā hui hou, a i ʻole ka loaʻa ʻana o ka ʻoihana.
No laila, ʻaʻohe wahi o kēia waihona i loko o kahi hoʻolālā hua; no ka ʻāpana kuhi ia o kahi waihona like ʻole, me ke kaumaha e pono ai ke mālama haʻahaʻa ʻia ka volatility o ka ʻāpana.
Pono anei ʻoe e kūʻai i ka waihona ʻo Molecular Partners i ka makahiki 2026?
Points forts :
- ʻO ka ʻenehana DARPin i hoʻokaʻawale ʻia, me kahi kahua modular i paʻakikī ke kope.
- ʻO ka paipu oncology lapaʻau, me kahi papahana pae 2 i nā ʻōpū paʻa.
- He ʻōnaehana biotech Swiss ikaika: kālena, kapikala a me ka hilinaʻi ʻepekema honua.
Nā mea e noʻonoʻo ai:
- ʻAʻohe huahana kālepa: ʻaʻole ola ka ʻoihana ma ke kūʻai aku ʻana, akā, ma kāna mau waihona kālā a me nā hui.
- Nā pilikia lapaʻau piha loa: hiki i kahi hāʻule ʻana o ka pae ke holoi i ka hapa nui o ka waiwai o ka papahana i nīnau ʻia.
- He pono paha no ke kālā e hiki mai ana, ka mea e hoʻohaʻahaʻa ai i nā mea kuleana o kēia manawa.
- Ka loli nui o ke kumukūʻai o nā mahele a puni nā hopena hoʻāʻo a me nā hoʻolaha hoʻokūkū.
- Ka palena o ke kālā ma Zurich a ʻaʻohe kūpono no PEA.
Hoʻolālā ʻo Molecular Partners i nā mea hoʻopukapuka kālā e hoʻomaopopo i ka pili biotech: kiʻekiʻe ka pilikia, akā he mau hiʻohiʻona no ka hoʻokumu waiwai ikaika inā hoʻokō ka ʻepekema i kāna mau ʻōlelo hoʻohiki. Pili piha ke kānāwai gula—ʻaʻole loa e hoʻolilo i kahi ʻoihana biotech lapaʻau i mea paʻa nui i ka waihona.
Ka loiloi kumu a me ka loea o ka waihona Molecular Partners
Kānāwai kumu
Ke nānā nei ka nānā ʻana i ʻekolu mau wahi koʻikoʻi: nā pae holomua a me ka wehewehe ʻana o nā hoʻokolohua MP0317 a me MP053, ke kahe kālā ʻupena a me kona ala holo, a me ka hiki ke hoʻopaʻa i nā hui like hou e hōʻoia i ka paepae. ʻO nā kamaʻilio ʻepekema—nā ʻaha kūkā, nā puke paʻi—he mea nui ia e like me nā hōʻike kālā i ka loiloi papa.
ʻIke loea
Ma Zurich, hana ke kumukūʻai e like me nā waihona biotech lapaʻau: ua haki nā wā lōʻihi o ke kali ʻana e nā loli o 10% a 30% i hoʻokahi kau, i hoʻokele ʻia e nā hoʻolaha. ʻAʻole nui ka waiwai wānana o ka loiloi loea kuʻuna ma aneʻi; ʻo ka hoʻokele pilikia—ka nui o ke kūlana, nā kū ākea akā paʻa, a me ka pale ʻana i ka awelika makapō—e mau ana ka mea nui, e like me kekahi hoʻolālā. kuai ana ma nā waiwai liʻiliʻi.
Pehea e kūʻai ai i ka ʻāpana o Molecular Partners?
- E koho i kahi mea kūʻai ke hāʻawi nei i ke komo ʻana i ka SIX Swiss Exchange: e hoʻohālikelike i nā kumukūʻai ma kā mākou koho o nā mea kūʻai waiwai maikaʻi loa.
- E wehe i kahi moʻokāki palekana maʻamau ʻAʻole komo ka waiwai Swiss i loko o kahi PEAi mālama ʻia no nā mea hoʻopuka ʻEulopa.
- E hoʻolilo i ka waihona kālā me nā uku hoʻololi euro-Swiss franc.
- E kau i ke kauoha ma ka MOLN mnemonic, me ke koi ma ke kumukūʻai palena: haʻahaʻa ke kahe kālā a pinepine nā ʻokoʻa kumukūʻai.
Nā hola kālepa
Ua wehe ʻia ka SIX Swiss Exchange mai ka hola 9:00 AM a i ka hola 17:30 PM manawa Swiss, ʻo ia hoʻi mai ka hola 9:00 AM a i ka hola 17:30 PM ma Palisa — ʻo ia ka ʻāpana manawa like. Kūʻai pākahi ʻia nā ʻāpana, me ka ʻole o nā ʻauhau ke kūʻai ʻia.
ʻAuhau
Ma kahi moʻokāki palekana maʻamau, pili nā loaʻa kālā kūpono i kahi ʻauhau paʻa o 30%. ʻOiai ʻaʻole uku ka ʻoihana i nā dividends, ʻaʻole ia e hoʻoulu i ka ʻauhau paʻa Swiss; i ka hana maoli, ua kaupalena ʻia ka ʻauhau i nā loaʻa kālā i ʻike ʻia.
Nā nīnau i nīnau pinepine ʻia e pili ana i ka waihona kālā Molecular Partners
Ma ka pāna kūʻai hea i helu ʻia ai ka waiwai o Molecular Partners?
Ma ka SIX Swiss Exchange ma Zurich, ma lalo o ka hōʻailona ticker MOLN, ma nā francs Swiss.
Ke uku nei ʻo Molecular Partners i kahi mahele kālā?
ʻAʻole. Aia ka ʻoihana i ke kahua lapaʻau a ke hoʻohana nei i kāna kālā e hoʻolako kālā i kāna mau hoʻokolohua; ʻaʻole loa ia i hāʻawi i kahi mahele.
Hiki ke hoʻokomo ʻia nā ʻāpana o Molecular Partners i loko o kahi PEA (hoʻolālā mālama kālā equity Farani)?
ʻAʻole. ʻO Swiss ka mea hoʻopuka, ma waho o ka European Economic Area: mālama ʻia ka palekana ma kahi moʻokāki palekana maʻamau.
He aha ke code ISIN no nā Molecular Partners?
ʻO CH0256379097, kūpono no ka laina i helu ʻia ma Zurich.
He aha ka pilikia nui o kēia waihona?
ʻO ka pilikia lapaʻau a me ke kālā o kahi ʻoihana biotech me ka ʻole o kahi huahana kālepa: ʻo ka hāʻule ʻana o ka hoʻāʻo ʻana a i ʻole ka pono no ka hoʻoponopono hou ʻana hiki ke hoʻolilo i ke kumukūʻai mahele e hāʻule nui a mau loa.
ʻŌlelo Hoʻolaha: No ka ʻike wale nō kēia ʻike a ʻaʻole ia he ʻōlelo aʻoaʻo hoʻopukapuka kālā. ʻO ka hoʻopukapuka kālā ʻana ma ka mākeke kūʻai e pili ana i ka pilikia o ka nalowale ʻana o ke kapikala; ʻaʻole hōʻike ka hana i hala i nā hopena e hiki mai ana.